Clinical Trials Browser

OTHER × Congenital Hyperinsulinism × Solutions × Clear all

NCT03053284 2021-05-14

Pasireotide in Hyperinsulinemic Hypoglycemia

Phase 2 Withdrawn

Hyperinsulinism, Insulinoma, Congenital Hyperinsulinism